Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 73

1.

Ab initio Lattice Results for Fermi Polarons in Two Dimensions.

Bour S, Lee D, Hammer HW, Meißner UG.

Phys Rev Lett. 2015 Oct 30;115(18):185301. doi: 10.1103/PhysRevLett.115.185301. Epub 2015 Oct 27.

PMID:
26565472
2.

Hormones and diet, but not body weight, control hypothalamic microglial activity.

Gao Y, Ottaway N, Schriever SC, Legutko B, García-Cáceres C, de la Fuente E, Mergen C, Bour S, Thaler JP, Seeley RJ, Filosa J, Stern JE, Perez-Tilve D, Schwartz MW, Tschöp MH, Yi CX.

Glia. 2014 Jan;62(1):17-25. doi: 10.1002/glia.22580. Epub 2013 Oct 28.

3.

Benzylamine antihyperglycemic effect is abolished by AOC3 gene invalidation in mice but not rescued by semicarbazide-sensitive amine oxidase expression under the control of aP2 promoter.

Grès S, Bour S, Valet P, Carpéné C.

J Physiol Biochem. 2012 Dec;68(4):651-62. doi: 10.1007/s13105-012-0171-1. Epub 2012 May 1.

PMID:
22547093
5.

Oral Administration of Semicarbazide Limits Weight Gain together with Inhibition of Fat Deposition and of Primary Amine Oxidase Activity in Adipose Tissue.

Mercader J, Iffiú-Soltész Z, Bour S, Carpéné C.

J Obes. 2011;2011:475786. doi: 10.1155/2011/475786. Epub 2011 Feb 8.

6.

Coenzyme Q as an antiadipogenic factor.

Bour S, Carmona MC, Galinier A, Caspar-Bauguil S, Van Gaal L, Staels B, Pénicaud L, Casteilla L.

Antioxid Redox Signal. 2011 Feb 1;14(3):403-13. doi: 10.1089/ars.2010.3350. Epub 2010 Nov 23.

PMID:
21091355
7.

Efficacy of a combination of imidacloprid 10%/moxidectin 2.5% spot-on (Advocate® for dogs) in the prevention of canine spirocercosis (Spirocerca lupi).

Le Sueur C, Bour S, Schaper R.

Parasitol Res. 2010 Nov;107(6):1463-9. doi: 10.1007/s00436-010-2022-8. Epub 2010 Aug 13.

8.

Adipose tissue lymphocytes: types and roles.

Caspar-Bauguil S, Cousin B, Bour S, Casteilla L, Penicaud L, Carpéné C.

J Physiol Biochem. 2009 Dec;65(4):423-36. doi: 10.1007/BF03185938. Review. Erratum in: J Physiol Biochem. 2011 Sep;67(3):497. Castiella, L [corrected to Casteilla, L].

PMID:
20358356
9.

Chronic benzylamine administration in the drinking water improves glucose tolerance, reduces body weight gain and circulating cholesterol in high-fat diet-fed mice.

Iffiú-Soltész Z, Wanecq E, Lomba A, Portillo MP, Pellati F, Szöko E, Bour S, Woodley J, Milagro FI, Alfredo Martinez J, Valet P, Carpéné C.

Pharmacol Res. 2010 Apr;61(4):355-63. doi: 10.1016/j.phrs.2009.12.014. Epub 2010 Jan 4.

PMID:
20045461
10.

dCAS: a desktop application for cDNA sequence annotation.

Guo Y, Ribeiro JM, Anderson JM, Bour S.

Bioinformatics. 2009 May 1;25(9):1195-6. doi: 10.1093/bioinformatics/btp129. Epub 2009 Mar 24.

11.

Semicarbazide-sensitive amine oxidase/vascular adhesion protein-1 deficiency reduces leukocyte infiltration into adipose tissue and favors fat deposition.

Bour S, Caspar-Bauguil S, Iffiú-Soltész Z, Nibbelink M, Cousin B, Miiluniemi M, Salmi M, Stolen C, Jalkanen S, Casteilla L, Pénicaud L, Valet P, Carpéné C.

Am J Pathol. 2009 Mar;174(3):1075-83. doi: 10.2353/ajpath.2009.080612. Epub 2009 Feb 13.

12.

Adipose tissue sensitivity to radiation exposure.

Poglio S, Galvani S, Bour S, André M, Prunet-Marcassus B, Pénicaud L, Casteilla L, Cousin B.

Am J Pathol. 2009 Jan;174(1):44-53. doi: 10.2353/ajpath.2009.080505. Epub 2008 Dec 18.

13.

Influence of acute and chronic administration of benzylamine on glucose tolerance in diabetic and obese mice fed on very high-fat diet.

Iffiú-Soltész' Z, Prévot D, Grés S, Bour S, Szökö E, Knauf C, Burcelin R, Fernández-Quintela A, Lomba A, Milagro FI, Carpéné C.

J Physiol Biochem. 2007 Dec;63(4):305-15.

PMID:
18457006
14.

Preclinical studies in rats and squirrel monkeys for safety evaluation of the bivalent anti-human T cell immunotoxin, A-dmDT390-bisFv(UCHT1).

Woo JH, Bour SH, Dang T, Lee YJ, Park SK, Andreas E, Kang SH, Liu JS, Neville DM Jr, Frankel AE.

Cancer Immunol Immunother. 2008 Aug;57(8):1225-39. doi: 10.1007/s00262-008-0457-x. Epub 2008 Feb 7.

PMID:
18256829
15.

Anthrax toxin-induced shock in rats is associated with pulmonary edema and hemorrhage.

Kuo SR, Willingham MC, Bour SH, Andreas EA, Park SK, Jackson C, Duesbery NS, Leppla SH, Tang WJ, Frankel AE.

Microb Pathog. 2008 Jun;44(6):467-72. doi: 10.1016/j.micpath.2007.12.001. Epub 2007 Dec 23.

PMID:
18222626
16.

DAVID Knowledgebase: a gene-centered database integrating heterogeneous gene annotation resources to facilitate high-throughput gene functional analysis.

Sherman BT, Huang da W, Tan Q, Guo Y, Bour S, Liu D, Stephens R, Baseler MW, Lane HC, Lempicki RA.

BMC Bioinformatics. 2007 Nov 2;8:426.

17.

Reduction of fat deposition by combined inhibition of monoamine oxidases and semicarbazide-sensitive amine oxidases in obese Zucker rats.

Carpéné C, Iffiú-Soltesz Z, Bour S, Prévot D, Valet P.

Pharmacol Res. 2007 Dec;56(6):522-30. Epub 2007 Sep 26.

PMID:
17977742
18.

Effects of histamine on triglyceride breakdown in mouse adipocytes.

Carpéné C, Bour S, Prévot D, Valet P.

Inflamm Res. 2007 Apr;56 Suppl 1:S41-2. No abstract available.

PMID:
17806173
19.

Myopathy associated with statin therapy.

Wahl D, Petitpain N, Frederic M, Bour S, Kaminsky P, Trechot P.

Neuromuscul Disord. 2007 Aug;17(8):661-2. Epub 2007 May 29. No abstract available.

PMID:
17537633
20.

Semicarbazide-sensitive amine oxidase substrates fail to induce insulin-like effects in fat cells from AOC3 knockout mice.

Bour S, Prévot D, Guigné C, Stolen C, Jalkanen S, Valet P, Carpéné C.

J Neural Transm (Vienna). 2007;114(6):829-33. Epub 2007 Apr 4.

PMID:
17406965
21.

Adipogenesis-related increase of semicarbazide-sensitive amine oxidase and monoamine oxidase in human adipocytes.

Bour S, Daviaud D, Gres S, Lefort C, Prévot D, Zorzano A, Wabitsch M, Saulnier-Blache JS, Valet P, Carpéné C.

Biochimie. 2007 Aug;89(8):916-25. Epub 2007 Feb 24.

PMID:
17400359
22.

Oral insulin-mimetic compounds that act independently of insulin.

García-Vicente S, Yraola F, Marti L, González-Muñoz E, García-Barrado MJ, Cantó C, Abella A, Bour S, Artuch R, Sierra C, Brandi N, Carpéné C, Moratinos J, Camps M, Palacín M, Testar X, Gumà A, Albericio F, Royo M, Mian A, Zorzano A.

Diabetes. 2007 Feb;56(2):486-93.

23.

Increased monoamine oxidase and semicarbazide-sensitive amine oxidase activities in white adipose tissue of obese dogs fed a high-fat diet.

Wanecq E, Bour S, Verwaerde P, Smih F, Valet P, Carpéné C.

J Physiol Biochem. 2006 Jun;62(2):113-23.

PMID:
17217165
24.
25.

The imidazoline I2-site ligands BU 224 and 2-BFI inhibit MAO-A and MAO-B activities, hydrogen peroxide production, and lipolysis in rodent and human adipocytes.

Bour S, Iglesias-Osma MC, Marti L, Duro P, Garcia-Barrado MJ, Pastor MF, Prévot D, Visentin V, Valet P, Moratinos J, Carpéné C.

Eur J Pharmacol. 2006 Dec 15;552(1-3):20-30. Epub 2006 Sep 23.

PMID:
17056035
26.

Short- and long-term insulin-like effects of monoamine oxidases and semicarbazide-sensitive amine oxidase substrates in cultured adipocytes.

Carpéné C, Daviaud D, Boucher J, Bour S, Visentin V, Grès S, Duffaut C, Fontana E, Testar X, Saulnier-Blache JS, Valet P.

Metabolism. 2006 Oct;55(10):1397-405.

PMID:
16979412
27.
28.

Glucose handling in streptozotocin-induced diabetic rats is improved by tyramine but not by the amine oxidase inhibitor semicarbazide.

Visentin V, Bour S, Boucher J, Prévot D, Valet P, Ordener C, Parini A, Carpéné C.

Eur J Pharmacol. 2005 Oct 17;522(1-3):139-46. Epub 2005 Oct 3.

PMID:
16202994
29.

Amine oxidase substrates for impaired glucose tolerance correction.

Carpéné C, Bour S, Visentin V, Pellati F, Benvenuti S, Iglesias-Osma MC, García-Barrado MJ, Valet P.

J Physiol Biochem. 2005 Jun;61(2):405-19. Review.

PMID:
16180339
30.

Effects of oral administration of benzylamine on glucose tolerance and lipid metabolism in rats.

Bour S, Visentin V, Prévot D, Daviaud D, Saulnier-Blache JS, Guigne C, Valet P, Carpéné C.

J Physiol Biochem. 2005 Jun;61(2):371-9.

PMID:
16180335
31.

Influence of high-fat diet on amine oxidase activity in white adipose tissue of mice prone or resistant to diet-induced obesity.

Visentin V, Boucher J, Bour S, Prévot D, Castan I, Carpéné C, Valet P.

J Physiol Biochem. 2005 Jun;61(2):343-52.

PMID:
16180332
32.

Methylamine but not mafenide mimics insulin-like activity of the semicarbazide-sensitive amine oxidase-substrate benzylamine on glucose tolerance and on human adipocyte metabolism.

Iglesias-Osma MC, Bour S, Garcia-Barrado MJ, Visentin V, Pastor MF, Testar X, Marti L, Enrique-Tarancon G, Valet P, Moratinos J, Carpéné C.

Pharmacol Res. 2005 Dec;52(6):475-84. Epub 2005 Aug 30.

PMID:
16135411
33.

Tyramine, benzylamine, and to a lesser extent histamine, partially mimic the adipogenic effect of insulin in a human preadipocyte cell strain.

Bour S, Visentin V, Gres S, Saulnier-Blache JS, Wabitsch M, Carpéné C.

Inflamm Res. 2005 Apr;54 Suppl 1:S60-1. No abstract available.

PMID:
15928836
34.

Mutual functional destruction of HIV-1 Vpu and host TASK-1 channel.

Hsu K, Seharaseyon J, Dong P, Bour S, Marbán E.

Mol Cell. 2004 Apr 23;14(2):259-67.

35.

Histamine does not induce an amine oxidase-dependent adipogenic effect in murine preadipocytes.

Subra C, Visentin V, Bour S, Fontana E, Prévot D, Carpéné C.

Inflamm Res. 2004 Mar;53 Suppl 1:S95-6. Epub 2004 Mar 5. No abstract available.

PMID:
15054637
36.

Codon optimization of the HIV-1 vpu and vif genes stabilizes their mRNA and allows for highly efficient Rev-independent expression.

Nguyen KL, llano M, Akari H, Miyagi E, Poeschla EM, Strebel K, Bour S.

Virology. 2004 Feb 20;319(2):163-75.

PMID:
15015498
37.

Effect of prolonged treatment with tyramine on glucose tolerance in streptozotocin-induced diabetic rats.

Visentin V, Marq P, Bour S, Subra C, Prévot D, Morin N, Valet P, Monje MC, Nepveu F, Carpéné C.

J Physiol Biochem. 2003 Sep;59(3):225-32.

PMID:
15000454
38.

Moderate weight-lowering effect of octopamine treatment in obese Zucker rats.

Bour S, Visentin V, Prévot D, Carpéné C.

J Physiol Biochem. 2003 Sep;59(3):175-82.

PMID:
15000448
39.

Benzylamine exhibits insulin-like effects on glucose disposal, glucose transport, and fat cell lipolysis in rabbits and diabetic mice.

Iglesias-Osma MC, Garcia-Barrado MJ, Visentin V, Pastor-Mansilla MF, Bour S, Prévot D, Valet P, Moratinos J, Carpéné C.

J Pharmacol Exp Ther. 2004 Jun;309(3):1020-8. Epub 2004 Feb 20.

PMID:
14978192
40.

Viral protein U counteracts a human host cell restriction that inhibits HIV-1 particle production.

Varthakavi V, Smith RM, Bour SP, Strebel K, Spearman P.

Proc Natl Acad Sci U S A. 2003 Dec 9;100(25):15154-9. Epub 2003 Dec 1.

41.

The HIV-1 Vpu protein: a multifunctional enhancer of viral particle release.

Bour S, Strebel K.

Microbes Infect. 2003 Sep;5(11):1029-39. Review.

PMID:
12941395
43.

Expression, purification, and activities of full-length and truncated versions of the integral membrane protein Vpu from HIV-1.

Ma C, Marassi FM, Jones DH, Straus SK, Bour S, Strebel K, Schubert U, Oblatt-Montal M, Montal M, Opella SJ.

Protein Sci. 2002 Mar;11(3):546-57.

45.

Human immunodeficiency virus type 1 Vif protein is packaged into the nucleoprotein complex through an interaction with viral genomic RNA.

Khan MA, Aberham C, Kao S, Akari H, Gorelick R, Bour S, Strebel K.

J Virol. 2001 Aug;75(16):7252-65.

46.
47.

HIV accessory proteins: multifunctional components of a complex system.

Bour S, Strebel K.

Adv Pharmacol. 2000;48:75-120. Review. No abstract available.

PMID:
10987089
48.

Molecular interactions of HIV with host factors.

Strebel K, Bour S.

AIDS. 1999;13 Suppl A:S13-24. Review. No abstract available.

PMID:
10885759
49.

Cell surface CD4 inhibits HIV-1 particle release by interfering with Vpu activity.

Bour S, Perrin C, Strebel K.

J Biol Chem. 1999 Nov 19;274(47):33800-6.

Supplemental Content

Support Center